Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Cyclica collaborates with Dalton Pharma Services
May 2013
SHARING OPTIONS:

TORONTO—Cyclica and Dalton Pharma Services have announced that they will be collaborating to jointly identify and develop several new drug candidates. The agreement will apply Cyclica's in-silico­ drug design and optimization services and databases to select lead molecules, several of which were previously developed by Dalton Medicinal Chemistry. Dalton Pharma Services will synthesize and manufacture the selected candidates for analysis and consideration for a global pharmaceutical company's candidate screening program. Cyclica and Dalton Pharma Services will equally own the resulting products.
 
"It is exciting to see Cyclica's advanced computational approach to molecule design paired with decades of medicinal chemistry and manufacturing experience from Dalton. This combination could significantly improve the way new drugs are developed," commented Jason Mitakidis, president and CEO of Cyclica.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.